Fit in the Aged by Professional Training (FiAT)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This intervention study tests training methods to stabilize or improve functionality in the high risk group of prefrail elderly persons.
| Condition | Intervention |
|---|---|
|
Frailty Sarcopenia |
Procedure: Power Training Procedure: Strength Training Other: Control |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | The Effect of Different Training Modalities and Vitamin D Supplementation on Functionality in Prefrail Elderly Persons |
- Short physical performance battery [ Time Frame: 3 months after intervention ] [ Designated as safety issue: Yes ]
- Muscle strength and muscle power [ Time Frame: 3 months after intervention ] [ Designated as safety issue: Yes ]
| Enrollment: | 69 |
| Study Start Date: | June 2008 |
| Study Completion Date: | May 2010 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: A
Training I
|
Procedure: Power Training
Power training, Vitamin D substitution
|
|
Experimental: B
Training II
|
Procedure: Strength Training
Strength training, Vitamin D substitution
|
|
Active Comparator: C
Control
|
Other: Control
Vitamin D substitution, Lifestyle consultation
|
Detailed Description:
This study aims at the improvement of muscular function by physical exercise in prefrail elderly persons. Prefrail participants are recruited according to the frailty score of Fried. Taking into account, that vitamin D supplementation reduces falls and improves muscle strength in older people, all participants are supplemented by vitamin D. Two different training methods are tested.
After a run-in period of supplementation of vitamin D for two months, participants will be randomized into three different equally sized groups (n=25): Group A will receive power training. Group B will have progressive strength training. Group C will serve as a control group. They will receive a consultation about leading a healthy life with special attention being paid to nutrition and physical activity. The intervention period lasts for 12 weeks. The 60 minutes training sessions will be held two times a week by members of the Institute of Sport Science and Sports of the University of Erlangen-Nuremberg. Follow-up visits are scheduled three and six months after intervention period.
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Prefrailty according to the frailty score of Fried
Exclusion Criteria:
- Sarcoidosis
- Nephrolithiasis
- Plasmacytoma
- COPD
- Inflammatory bowel disease
- Rheumatoid arthritis
- History of cancer
- Instable heart disease
- Depression (GDS>=6)
- Dementia (MMSE<=24)
- BMI>35kg/m²
- Current attendance of muscle training
- Medication: immunosuppressive drugs
Contacts and Locations| Germany | |
| Institute of Biomedicine of Aging | |
| Nuremberg, Germany, 90419 | |
| Principal Investigator: | Cornel C. Sieber, Prof. Dr. | University of Erlangen-Nuremberg |
| Principal Investigator: | Klaus Pfeifer, Prof. Dr. | University of Erlangen-Nuremberg |
More Information
No publications provided by University of Erlangen-Nürnberg Medical School
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Prof. Dr. Cornel Sieber, Institute of Biomedicine of Aging |
| ClinicalTrials.gov Identifier: | NCT00783159 History of Changes |
| Other Study ID Numbers: | 32.5.8051.0113.0 |
| Study First Received: | October 30, 2008 |
| Last Updated: | January 11, 2011 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by University of Erlangen-Nürnberg Medical School:
|
Muscle power Frailty Exercise Vitamin D |
Additional relevant MeSH terms:
|
Sarcopenia Muscular Atrophy Neuromuscular Manifestations Neurologic Manifestations Nervous System Diseases Atrophy Pathological Conditions, Anatomical Signs and Symptoms |
Vitamin D Ergocalciferols Vitamins Bone Density Conservation Agents Physiological Effects of Drugs Pharmacologic Actions Micronutrients Growth Substances |
ClinicalTrials.gov processed this record on May 19, 2013